{"resourceType":"Bundle","id":"tests-1a4d1c2a-0681-4c42-8f9a-2faf393b6ad3-bundle","type":"transaction","entry":[{"fullUrl":"https://madie.cms.gov/Patient/1a4d1c2a-0681-4c42-8f9a-2faf393b6ad3","resource":{"resourceType":"Patient","id":"1a4d1c2a-0681-4c42-8f9a-2faf393b6ad3","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-patient"]},"extension":[{"url":"http://hl7.org/fhir/us/core/StructureDefinition/us-core-race","extension":[{"url":"ombCategory","valueCoding":{"system":"urn:oid:2.16.840.1.113883.6.238","code":"1002-5","display":"American Indian or Alaska Native","userSelected":true}},{"url":"text","valueString":"American Indian or Alaska Native"}]},{"url":"http://hl7.org/fhir/us/core/StructureDefinition/us-core-ethnicity","extension":[{"url":"ombCategory","valueCoding":{"system":"urn:oid:2.16.840.1.113883.6.238","code":"2186-5","display":"Not Hispanic or Latino","userSelected":true}},{"url":"text","valueString":"Not Hispanic or Latino"}]}],"identifier":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/v2-0203","code":"MR"}]},"system":"https://bonnie-fhir.healthit.gov/","value":"62fd0fbb85b0356a7c285333"}],"name":[{"family":"DenomFail","given":["GleasonAfter1stTxValueLessThan6"]}],"gender":"male","birthDate":"1992-09-17"},"request":{"method":"PUT","url":"Patient/1a4d1c2a-0681-4c42-8f9a-2faf393b6ad3"}},{"fullUrl":"https://madie.cms.gov/Condition/prostate-cancer-a8d8","resource":{"resourceType":"Condition","id":"44d0514d-9266-4ebb-9cdc-6f603be040c1","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-condition"]},"clinicalStatus":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/condition-clinical","code":"active","display":"active","userSelected":true}]},"category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/condition-category","code":"problem-list-item","display":"Problem List Item"}]}],"code":{"coding":[{"system":"http://snomed.info/sct","version":"2022-03","code":"254900004","display":"Carcinoma of prostate (disorder)","userSelected":true}]},"subject":{"reference":"Patient/1a4d1c2a-0681-4c42-8f9a-2faf393b6ad3"},"onsetPeriod":{"start":"2021-06-14T08:00:00.000+00:00"}},"request":{"method":"PUT","url":"Condition/44d0514d-9266-4ebb-9cdc-6f603be040c1"}},{"fullUrl":"https://madie.cms.gov/Procedure/prostate-cancer-treatment-a8d9","resource":{"resourceType":"Procedure","id":"9c04df22-a7d0-4f0c-a527-1cfa23a3ea7c","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-procedure"]},"extension":[{"url":"http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-recorded","valueDateTime":"2025-02-01T09:00:00.000+00:00"}],"status":"completed","code":{"coding":[{"system":"http://snomed.info/sct","version":"2022-03","code":"10492003","display":"Radionuclide therapy for glandular suppression (procedure)","userSelected":true}]},"subject":{"reference":"Patient/1a4d1c2a-0681-4c42-8f9a-2faf393b6ad3"},"performedDateTime":"2025-04-28T08:00:00.000+00:00"},"request":{"method":"PUT","url":"Procedure/9c04df22-a7d0-4f0c-a527-1cfa23a3ea7c"}},{"fullUrl":"https://madie.cms.gov/Observation/prostate-specific-antigen-test-a8db","resource":{"resourceType":"Observation","id":"f45e3dce-9c1a-4de8-806d-0767f8ae664f","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-observation"]},"status":"final","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/observation-category","code":"procedure","display":"Procedure"}]}],"code":{"coding":[{"system":"http://loinc.org","version":"2.72","code":"10508-0","display":"Prostate specific Ag [Presence] in Tissue by Immune stain","userSelected":true}]},"subject":{"reference":"Patient/1a4d1c2a-0681-4c42-8f9a-2faf393b6ad3"},"effectiveDateTime":"2025-02-02T08:00:00.000+00:00","valueQuantity":{"value":5.0,"system":"http://unitsofmeasure.org","code":"ng/mL"}},"request":{"method":"PUT","url":"Observation/f45e3dce-9c1a-4de8-806d-0767f8ae664f"}},{"fullUrl":"https://madie.cms.gov/Observation/gleason-score-in-specimen-qualitative-a8dc","resource":{"resourceType":"Observation","id":"056ec082-3394-42c0-b628-44bd4dbaf36a","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-observation"]},"status":"final","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/observation-category","code":"procedure","display":"Procedure"}]}],"code":{"coding":[{"system":"http://loinc.org","code":"35266-6","display":"Gleason score in Specimen Qualitative","userSelected":true}]},"subject":{"reference":"Patient/1a4d1c2a-0681-4c42-8f9a-2faf393b6ad3"},"effectiveDateTime":"2025-08-17T08:00:00.000+00:00","valueInteger":5},"request":{"method":"PUT","url":"Observation/056ec082-3394-42c0-b628-44bd4dbaf36a"}},{"fullUrl":"https://madie.cms.gov/Observation/tumor-staging-tumor-staging-a8dd","resource":{"resourceType":"Observation","id":"8dc2dbfb-c4e8-4b1f-80d7-4e7a81b4f14d","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-observation"]},"status":"final","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/observation-category","code":"procedure","display":"Procedure"}]}],"code":{"coding":[{"system":"http://snomed.info/sct","code":"254292007","display":"Tumor staging (tumor staging)","userSelected":true}]},"subject":{"reference":"Patient/1a4d1c2a-0681-4c42-8f9a-2faf393b6ad3"},"effectiveDateTime":"2025-04-27T23:59:00.000+00:00","valueCodeableConcept":{"coding":[{"system":"http://snomed.info/sct","code":"433351000124101","display":"Neoplasm of prostate primary tumor staging category T1c: Tumor identified by needle biopsy (finding)","userSelected":true}]}},"request":{"method":"PUT","url":"Observation/8dc2dbfb-c4e8-4b1f-80d7-4e7a81b4f14d"}},{"fullUrl":"https://madie.cms.gov/Coverage/1","resource":{"resourceType":"Coverage","id":"398d21e7-d9c3-4eb1-996a-0981557d670e","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-coverage"]},"status":"active","beneficiary":{"reference":"Patient/1a4d1c2a-0681-4c42-8f9a-2faf393b6ad3"},"payor":[{"reference":"Organization/4b5a882f-1f43-485c-85c6-f5ad2337d5b1"}]},"request":{"method":"PUT","url":"Coverage/398d21e7-d9c3-4eb1-996a-0981557d670e"}},{"fullUrl":"https://madie.cms.gov/Organization/123456","resource":{"resourceType":"Organization","id":"4b5a882f-1f43-485c-85c6-f5ad2337d5b1","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-organization"]},"identifier":[{"use":"temp","system":"urn:oid:2.16.840.1.113883.4.4","value":"21-3259825"}],"active":true,"type":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/organization-type","code":"pay","display":"Payer"}]}],"name":"Blue Cross Blue Shield of Texas","telecom":[{"system":"phone","value":"(+1) 972-766-6900"}],"address":[{"use":"billing","type":"postal","line":["P.O. Box 660044"],"city":"Dallas","state":"TX","postalCode":"75266-0044","country":"USA"}]},"request":{"method":"PUT","url":"Organization/4b5a882f-1f43-485c-85c6-f5ad2337d5b1"}},{"fullUrl":"https://madie.cms.gov/Practitioner/practitioner-123456","resource":{"resourceType":"Practitioner","id":"289d4a6c-3b19-454f-8d55-bb231267c198","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-practitioner"]},"identifier":[{"system":"http://hl7.org/fhir/sid/us-npi","value":"123456"}],"name":[{"family":"Evil","prefix":["Dr"]}]},"request":{"method":"PUT","url":"Practitioner/289d4a6c-3b19-454f-8d55-bb231267c198"}},{"fullUrl":"https://madie.cms.gov/MeasureReport/2605b93f-ec15-4e5b-a0c4-27bd41e8ec18","resource":{"resourceType":"MeasureReport","id":"2605b93f-ec15-4e5b-a0c4-27bd41e8ec18","meta":{"profile":["http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/test-case-cqfm"]},"contained":[{"resourceType":"Parameters","id":"fb0289f2-9167-4d32-9404-ae1aec4a9248-parameters","parameter":[{"name":"subject","valueString":"1a4d1c2a-0681-4c42-8f9a-2faf393b6ad3"}]}],"extension":[{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-inputParameters","valueReference":{"reference":"#fb0289f2-9167-4d32-9404-ae1aec4a9248-parameters"}},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-testCaseDescription","valueMarkdown":"Prostate Ca Diagnosis but does not meet Gleason. Meets tumor staging. first treatment, and  PSA.  Gleason is after 1st cancer treatment.  Value < 6.\n"}],"modifierExtension":[{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-isTestCase","valueBoolean":true}],"status":"complete","type":"individual","measure":"https://madie.cms.gov/Measure/ProstateCaAvoidanceBoneScanOveruseFHIR","period":{"start":"2025-01-01","end":"2025-12-31"},"group":[{"population":[{"code":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/measure-population","code":"initial-population","display":"Initial Population"}]},"count":1},{"code":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/measure-population","code":"denominator","display":"Denominator"}]},"count":0},{"code":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/measure-population","code":"numerator","display":"Numerator"}]},"count":0},{"code":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/measure-population","code":"denominator-exception","display":"Denominator Exception"}]},"count":0}]}]},"request":{"method":"PUT","url":"MeasureReport/2605b93f-ec15-4e5b-a0c4-27bd41e8ec18"}}]}